Literature DB >> 3736906

Intraoperative embolization of cerebral arteriovenous malformations.

H A van Alphen.   

Abstract

Nineteen patients with large cortical or deep seated cerebral arteriovenous malformation (AVM) were treated with intraoperative embolization using bucrylate (isobutyl-2-cyanoacrylate, IBC). In three cases of medium-sized AVM, the procedure was followed by a total excision of the lesion during the same operation. The results were excellent. In one case a hematoma and brain swelling following embolization necessitated total removal immediately afterwards. In eight patients embolization was carried out in two or three stages, to achieve a gradual obliteration of the shunt and to diminish the risk of postoperative brain swelling. Nevertheless, in three of these patients, postoperative hemiplegia was seen, which, however, improved considerably over a 1-2 year period. Complete occlusion of the shunt was obtained in only two patients. Seven patients underwent single-stage embolization, which resulted in partial obliteration of the AVM in six of them. In two of these, this treatment had been proposed for the accompanying symptoms of seizures and ischemic attacks. In all but one case the epileptic seizures decreased or disappeared completely after embolization. One patient suffered intracerebral bleeding three months after partial obliteration. Mortality was zero. It is argued that an alteration of the cerebral circulation with subsequent hyperemia is the most important sequela of rapid obliteration of large AVMs. Some details concerning the structure of cerebral AVMs are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3736906     DOI: 10.1007/bf01743056

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  18 in total

1.  Letter: Intracranial cyanoacrylate: a new catheter therapy for arteriovenous malformation.

Authors:  C Kerber
Journal:  Invest Radiol       Date:  1975 Sep-Oct       Impact factor: 6.016

2.  Surgical versus conservative treatment of intracranial arteriovenous malformations: a study in surgical decision-making.

Authors:  L Pellettieri; C A Carlsson; S Grevsten; G Norlén; C Uhlemann
Journal:  Acta Neurochir Suppl (Wien)       Date:  1979

3.  Arteriovenous malformations of the brain. Prognosis without operation.

Authors:  H Troupp; I Marttila; V Halonen
Journal:  Acta Neurochir (Wien)       Date:  1970       Impact factor: 2.216

4.  Intraoperative embolization of cerebral arteriovenous malformations in the awake patient.

Authors:  J P Girvin; A J Fox; F Vinuela; C G Drake
Journal:  Clin Neurosurg       Date:  1983

5.  Normal perfusion pressure breakthrough theory.

Authors:  R F Spetzler; C B Wilson; P Weinstein; M Mehdorn; J Townsend; D Telles
Journal:  Clin Neurosurg       Date:  1978

6.  Treatment of cerebral arteriovenous malformations: a combined neurosurgical and neuroradiological approach.

Authors:  L D Cromwell; A B Harris
Journal:  J Neurosurg       Date:  1980-05       Impact factor: 5.115

7.  Natural history of cerebral angiomas.

Authors:  W R Henderson; R D Gomez
Journal:  Br Med J       Date:  1967-12-09

8.  Natural history of arteriovenous malformations of the brain: a clinical study.

Authors:  D Fults; D L Kelly
Journal:  Neurosurgery       Date:  1984-11       Impact factor: 4.654

9.  Intravascular use of isobutyl 2-cyanoacrylate: Part 1 Treatment of intracranial arteriovenous malformations.

Authors:  D Samson; Q M Ditmore; C W Beyer
Journal:  Neurosurgery       Date:  1981-01       Impact factor: 4.654

10.  [Intra operative embolization of unresectable cerebral arterio-venous malformations. Occlusion attempt by means of a delayed polymerization mixture. Report of two cases (author's transl)].

Authors:  R Deruty; C Lapras; P Bret; F Taboada; R Duthel
Journal:  Neurochirurgie       Date:  1981       Impact factor: 1.553

View more
  1 in total

1.  Intraoperative angiography and embolization in intracranial AVM's and aneurysms.

Authors:  H P Molsen; A Gräwe; G Nisch; H Rost; W D Siedschlag
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.